Boston Scientific Corporation
BSX
$64.61
+1.24% (+$0.79)
Chart by TradingView — for analysis only.
Key Statistics
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS
—
Dividend Yield
—
52W High
$109.50
52W Low
$60.59
Avg Volume
14.2M
Healthcare
Medical Devices
Some fundamental metrics are unavailable; 52-week range and average volume may still come from live quotes.
About Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets a broad portfolio of medical devices designed for minimally invasive procedures worldwide. The company specializes in innovative technologies that address critical health needs across cardiology, endoscopy, and neuromodulation. Its Cardiovascular segment offers products for angioplasty, stents, cardiac rhythm management, and structural heart interventions, while the MedSurg segment provides solutions for endoscopy, urology, neuromodulation for chronic pain, interventional oncology, and treatments for incontinence and kidney stones. These devices enable healthcare professionals to perform precise diagnostics and therapies with reduced patient recovery times. Boston Scientific Corporation serves physicians, hospitals, and healthcare institutions globally, with a significant portion of sales from international markets. Founded in 1979 and headquartered in Marlborough, Massachusetts, it plays a vital role in advancing interventional medicine and improving patient outcomes in high-volume therapeutic areas.
Company website →Earnings
- Next Earnings
- 2026-04-20
- Days Until
- 4d
- Status
- UPCOMING
- Analyst
- SELL · 6.5/10 (MTF)
- Price Target
- $63.54
Quarterly Results
| Quarter | Revenue | EPS |
|---|---|---|
| 2026-04-20 | — | — |
| 2026-02-04 | — | $0.80 |
| 2025-10-22 | — | $0.75 |
| 2025-10-08 | — | $0.04 |
| 2025-07-23 | — | $0.75 |
Related Tools
Plan and size trades
Free calculators on the site — same tools linked from the home page. Not financial advice.
- Position Size Calculator
How many shares to buy for your risk budget.
- Risk/Reward Calculator
See if a setup meets your minimum R:R.
- Profit/Loss Calculator
Estimate dollar P/L before you enter.
- P/E Ratio Calculator
Quick valuation check from price and EPS.
- Intrinsic Value (DCF)
Rough fair value from cash-flow assumptions.
- Market Overview
Breadth, indices, and context at a glance.
FAQ
Boston Scientific Corporation develops, manufactures, and markets a broad portfolio of medical devices designed for minimally invasive procedures worldwide. The company specializes in innovative technologies that address critical health needs across cardiology, endoscopy, and neuromodulation. Its Cardiovascular segment offers products for angioplasty, stents, cardiac rhythm management, and structural heart interventions, while the MedSurg segment provides solutions for endoscopy, urology, neuromodulation for chronic pain, interventional oncology, and treatments for incontinence and kidney stones. These devices enable healthcare professionals to perform precise diagnostics and therapies with reduced patient recovery times. Boston Scientific Corporation serves physicians, hospitals, and healthcare institutions globally, with a significant portion of sales from international markets. Founded in 1979 and headquartered in Marlborough, Massachusetts, it plays a vital role in advancing interventional medicine and improving patient outcomes in high-volume therapeutic areas.